Psoriasis patient preferences for topical drugs: a systematic review

Background Topical drugs are recommended first-line treatment for mild-to-moderate psoriasis. However, patient preferences for the topical drugs differ, since a wide variety of topical drugs and topical drug formulations are available. Objectives The aim of this study was to investigate psoriasis pa...

Full description

Bibliographic Details
Main Authors: Mathias Tiedemann Svendsen, Steven R. Feldman, Sylvia Naiga Tiedemann, Anne Sofie Stochholm Sørensen, Cecilie Marie Ringgaard Rivas, Klaus Ejner Andersen
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2019.1675855
_version_ 1797683650119073792
author Mathias Tiedemann Svendsen
Steven R. Feldman
Sylvia Naiga Tiedemann
Anne Sofie Stochholm Sørensen
Cecilie Marie Ringgaard Rivas
Klaus Ejner Andersen
author_facet Mathias Tiedemann Svendsen
Steven R. Feldman
Sylvia Naiga Tiedemann
Anne Sofie Stochholm Sørensen
Cecilie Marie Ringgaard Rivas
Klaus Ejner Andersen
author_sort Mathias Tiedemann Svendsen
collection DOAJ
description Background Topical drugs are recommended first-line treatment for mild-to-moderate psoriasis. However, patient preferences for the topical drugs differ, since a wide variety of topical drugs and topical drug formulations are available. Objectives The aim of this study was to investigate psoriasis patient preferences for topical drugs. Methods A systematic literature search was performed for English-language articles in Embase, Medline, PsycINFO, Cinahl, Scopus, and the Cochrane Library. Results Four surveys, six randomized controlled trials, and two prospective studies of mainly good quality were included. Seven of the studies investigated patient preferences for topical drug formulations, while five studies investigated their preferences for different topical drugs. Overall, patients preferred drugs that are easy to apply, less messy, and have a pleasant scent. Conclusion Psoriasis patient preferences for topical drugs differ. There is no one topical drug or topical drug formulation that suits everyone, which shows the importance of individualized prescriptions for topical drugs that are based on shared decision-making between the prescriber and patient.
first_indexed 2024-03-12T00:17:37Z
format Article
id doaj.art-03f52075fb8e4f24981904394bbd7c30
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:17:37Z
publishDate 2021-07-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-03f52075fb8e4f24981904394bbd7c302023-09-15T14:23:03ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532021-07-0132547848310.1080/09546634.2019.16758551675855Psoriasis patient preferences for topical drugs: a systematic reviewMathias Tiedemann Svendsen0Steven R. Feldman1Sylvia Naiga Tiedemann2Anne Sofie Stochholm Sørensen3Cecilie Marie Ringgaard Rivas4Klaus Ejner Andersen5Research Unit of the Dermato-Venerology and Allergy Center, University of Southern DenmarkResearch Unit of the Dermato-Venerology and Allergy Center, University of Southern DenmarkFaculty of Medicine and Health Sciences, University of CopenhagenDepartment of Nursing in Copenhagen, Metropol University CollegeDepartment of Nursing in Copenhagen, Metropol University CollegeResearch Unit of the Dermato-Venerology and Allergy Center, University of Southern DenmarkBackground Topical drugs are recommended first-line treatment for mild-to-moderate psoriasis. However, patient preferences for the topical drugs differ, since a wide variety of topical drugs and topical drug formulations are available. Objectives The aim of this study was to investigate psoriasis patient preferences for topical drugs. Methods A systematic literature search was performed for English-language articles in Embase, Medline, PsycINFO, Cinahl, Scopus, and the Cochrane Library. Results Four surveys, six randomized controlled trials, and two prospective studies of mainly good quality were included. Seven of the studies investigated patient preferences for topical drug formulations, while five studies investigated their preferences for different topical drugs. Overall, patients preferred drugs that are easy to apply, less messy, and have a pleasant scent. Conclusion Psoriasis patient preferences for topical drugs differ. There is no one topical drug or topical drug formulation that suits everyone, which shows the importance of individualized prescriptions for topical drugs that are based on shared decision-making between the prescriber and patient.http://dx.doi.org/10.1080/09546634.2019.1675855patient preferencespsoriasistopical drugs
spellingShingle Mathias Tiedemann Svendsen
Steven R. Feldman
Sylvia Naiga Tiedemann
Anne Sofie Stochholm Sørensen
Cecilie Marie Ringgaard Rivas
Klaus Ejner Andersen
Psoriasis patient preferences for topical drugs: a systematic review
Journal of Dermatological Treatment
patient preferences
psoriasis
topical drugs
title Psoriasis patient preferences for topical drugs: a systematic review
title_full Psoriasis patient preferences for topical drugs: a systematic review
title_fullStr Psoriasis patient preferences for topical drugs: a systematic review
title_full_unstemmed Psoriasis patient preferences for topical drugs: a systematic review
title_short Psoriasis patient preferences for topical drugs: a systematic review
title_sort psoriasis patient preferences for topical drugs a systematic review
topic patient preferences
psoriasis
topical drugs
url http://dx.doi.org/10.1080/09546634.2019.1675855
work_keys_str_mv AT mathiastiedemannsvendsen psoriasispatientpreferencesfortopicaldrugsasystematicreview
AT stevenrfeldman psoriasispatientpreferencesfortopicaldrugsasystematicreview
AT sylvianaigatiedemann psoriasispatientpreferencesfortopicaldrugsasystematicreview
AT annesofiestochholmsørensen psoriasispatientpreferencesfortopicaldrugsasystematicreview
AT ceciliemarieringgaardrivas psoriasispatientpreferencesfortopicaldrugsasystematicreview
AT klausejnerandersen psoriasispatientpreferencesfortopicaldrugsasystematicreview